Hypertension-associated hospitalizations and costs in the United States, 1979-2006
- PMID: 23885763
- PMCID: PMC4544734
- DOI: 10.3109/08037051.2013.814751
Hypertension-associated hospitalizations and costs in the United States, 1979-2006
Abstract
Background and objective: In the USA, the prevalence of hypertension has been high and increasing in recent decades. Even so, little is known about the changes over time in hospitalizations and the economic burden associated with this epidemic. We examined hypertension-associated hospitalizations and costs from 1979 to 2006.
Methods: Using the National Hospital Discharge Survey and the costs of community hospitals in the USA, we analyzed the changes in hypertension-associated hospitalizations and costs over time. We included those hospitalizations with a primary or secondary diagnosis of hypertension among patients aged 25 years and above. We examined changes in costs by adjusting them into year 2008 dollars. The costs included hospital expenses of payroll, employee benefits, professional fees and supplies.
Results: From 1979-1982 to 2003-2006, the proportion of hospitalizations that were associated with hypertension (primary or secondary diagnosis) increased from 1.9% to 5.4%. Among all hypertension-associated hospitalizations, the proportion with a secondary diagnosis of hypertension increased from 81.8% to 95.1%. In 2008 dollars, annual costs for hypertension-related hospitalizations increased from US$40 billion (5.1% of total hospital costs) during 1979-1982 to US$113 billion (15.1% of total hospital costs) during 2003-2006.
Conclusions: Both the proportions of hospitalizations that were associated with hypertension and the adjusted annual costs of such hospitalizations nearly tripled over the past 28 years. The increases were in substantial measure due to the greatly increasing proportion of hospitalizations in which hypertension was listed as a secondary diagnosis. Interventions for the management of hypertension as a secondary diagnosis might be potentially cost-effective.
Conflict of interest statement
Figures
Similar articles
-
Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.JAMA Netw Open. 2020 Apr 1;3(4):e201997. doi: 10.1001/jamanetworkopen.2020.1997. JAMA Netw Open. 2020. PMID: 32239220 Free PMC article.
-
What Is the Financial Impact of Orthopaedic Sequelae of Intravenous Drug Use on Urban Tertiary-care Centers?Clin Orthop Relat Res. 2020 Oct;478(10):2202-2212. doi: 10.1097/CORR.0000000000001330. Clin Orthop Relat Res. 2020. PMID: 32667752 Free PMC article.
-
Congenital cytomegalovirus-related hospitalizations in infants <1 year of age, United States, 1997-2009.Pediatr Infect Dis J. 2014 Nov;33(11):1119-23. doi: 10.1097/INF.0000000000000421. Pediatr Infect Dis J. 2014. PMID: 24871641 Free PMC article.
-
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.J Manag Care Pharm. 2010 May;16(4):264-75. doi: 10.18553/jmcp.2010.16.4.264. J Manag Care Pharm. 2010. PMID: 20433217 Free PMC article.
-
National Costs for Cardiovascular-Related Hospitalizations and Inpatient Procedures in the United States, 2016 to 2021.Am J Cardiol. 2025 Jan 1;234:63-70. doi: 10.1016/j.amjcard.2024.10.003. Epub 2024 Oct 23. Am J Cardiol. 2025. PMID: 39454699
Cited by
-
Relationship between a Weighted Multi-Gene Algorithm and Blood Pressure Control in Hypertension.J Clin Med. 2019 Feb 28;8(3):289. doi: 10.3390/jcm8030289. J Clin Med. 2019. PMID: 30823438 Free PMC article.
-
Incidence of Hypertension-Related Emergency Department Visits in the United States, 2006 to 2012.Am J Cardiol. 2015 Dec 1;116(11):1717-23. doi: 10.1016/j.amjcard.2015.09.007. Epub 2015 Sep 10. Am J Cardiol. 2015. PMID: 26454813 Free PMC article.
-
Medical Expenditures Associated With Hypertension in the U.S., 2000-2013.Am J Prev Med. 2017 Dec;53(6S2):S164-S171. doi: 10.1016/j.amepre.2017.05.014. Am J Prev Med. 2017. PMID: 29153117 Free PMC article.
-
A global perspective on the costs of hypertension: a systematic review.Arch Med Sci. 2020 Jan 31;16(5):1078-1091. doi: 10.5114/aoms.2020.92689. eCollection 2020. Arch Med Sci. 2020. PMID: 32863997 Free PMC article. Review.
-
Profile of hypertension in Turkey: from prevalence to patient awareness and compliance with therapy, and a focus on reasons of increase in hypertension among youths.J Hum Hypertens. 2022 May;36(5):437-444. doi: 10.1038/s41371-020-00480-6. Epub 2021 Jan 18. J Hum Hypertens. 2022. PMID: 33462387 Review.
References
-
- Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension. 2004;44:398–404. - PubMed
-
- Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control – continued disparities in adults : United States, 2005–2006. NCHS Data Brief. 2008:1–8. - PubMed
-
- Chobanian AV, Bakris GL, Black HR, et al. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572. - PubMed
-
- Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755–1762. - PubMed
-
- Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiologic context. Lancet. 1990;335:827–838. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous